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Received April 26, 2012; accepted August 9, 2012AbstractBackground: Hepatic steatosis is defined as excessive amounts of triglyceride and other fats inside liver cells and has become an emergent liver
disease in developed and developing countries.
Methods: Deep seawater (DSW)300, DSW900, and DSW1500 drinking waters were formulated via a combination of reverse osmosis and
electrodialysis. Hamsters on a high-fat diet were assigned to drink the following solutions: (1) normal distilled water, (2) DSW300, (3) DSW900,
or (4) DSW1500. Serum, liver, and fecal biochemical values, expression of hepatic genes related to fatty-acid homeostasis, as well as liver
antioxidative levels were measured after a 6-week feeding period. Additionally, hematoxylin and eosin staining was used to investigate the liver
histopathology.
Results: Serum/liver lipids, liver sizes, liver malondialdehyde content, and serum aspartate aminotransferase and alanine aminotransferase of
high-fat diet hamsters were reduced ( p < 0.05) by drinking DSW, while daily fecal lipid and bile acid outputs were increased ( p < 0.05). DSW
drinking water maintained ( p < 0.05) higher liver glutathione and Trolox equivalent antioxidant capacity levels. Although hepatic sterol
regulatory element-binding protein-1c, acetyl-CoA carboxylase, fatty acid synthase, and malic enzyme gene expression were not ( p > 0.05)
altered, DSW drinking water upregulated ( p < 0.05) hepatic peroxisome proliferator-activated receptor-alpha, retinoid X receptor alpha, and
uncoupling protein-2 gene expression in high-fat diet hamsters. The lipid droplets in livers were also reduced in DSW-drinking-water groups as
compared to those only drinking distilled water.
Conclusion: DSW shows a preventive effect on development of hepatosteatosis induced by a high-fat diet.
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A hypercaloric dietary habit easily results in increased body
weight, serum lipids, and hepatic lipid accumulation. Hepatic
steatosis is defined as excessive amounts of triglyceride and
other fats inside liver cells and has become an emergent liver
disease with prevalence estimated to be 20e30% the in
general population of Western countries.1,2 Generally, hepatichinese Medical Association. All rights reserved.
Table 1
Mineral contents of different drinking solutions.
NDW DSW300 DSW900 DSW1500
Na (mg/L) 0.49 212.00 305.00 380.00
K (mg/L) 0.10 13.00 20.48 27.80
Ca (mg/L) 0.28 12.50 48.00 65.00
Mg (mg/L) 0.38 68.00 188.00 330.60
Hardness (ppm) 2.26 310.05 890.80 1517.96
Hardness (ppm) ¼ Ca (mg/L)  2.5 þ Mg (mg/L)  4.1.26
DSW300 ¼ 310.05 ppm deep-seawater drinking water; DSW900 ¼
890.80 ppm deep-seawater drinking water; DSW1500 ¼ 1517.96 ppm deep-
seawater drinking water; NDW ¼ normal distilled water.
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diabetes, and hyperlipidemia.3 In addition, increased liver lipid
accumulation causes lipid peroxidation, further advancing
liver damage. Hence, the clinical implications of hepatic
steatosis are mostly due to its potential to cause a chronic
inflammation and then progress to cirrhosis, liver failure, and
hepatocellular carcinoma.
Deep seawater (DSW) designates water from 200 m below
the surface of the sea. DSW is characterized by high purity,
low temperature, high nutrients, and minerals, and has
recently been tested in trials as a multifunctional material for
the food, agricultural, cosmetic, and medical fields. DSW has
also been reported to contain high levels of minerals, such as
magnesium (Mg), calcium (Ca), and potassium (K) compared
with surface and middle seawater.4,5 It was reported that DSW
(hardness: 1000 ppm) shows an amelioration of body-weight
increase, blood sugar, and serum lipids in ob/ob mice.6
Recently, the health effects of DSW from sea water below
700 m in the outer sea of Hua-Lien County, Taiwan have been
demonstrated.7 It was also reported that electrodialysis
(ED)-treated DSW (ED DSW; hardness: 4685.90 ppm) could
decrease serum lipids and improve blood cholesterol profile.7
However, from the viewpoint health food development, ED
DSW contains very high concentrations of minerals that may
cause dangers for heart or kidney. Hence, we have formulated
drinking waters from DSW (hardness: 300, 900, and
1500 ppm) via a combination of reverse osmosis (RO) and
ED, and observed that those DSW drinking waters could
upregulate expression of hepatic low-density-lipoprotein
receptor and cholesterol-7a-hydroxylase genes to lower
serum cholesterol levels, and concurrently decrease serum
lipid oxidative levels.8
Normalizing serum lipids is also known to be a way to
hinder the occurrence of hepatic steatosis. The sources of body
triglycerides are mainly diet and de novo synthesis. Hepatic
fatty-acid homeostasis in mammals is regulated by fatty-acid
biosynthesis (i.e. sterol regulatory element-binding protein-
1c, SREBP-1c; acetyl-CoA carboxylase, ACC; fatty acid
synthase, FAS; malic enzyme, ME)9 and energy expenditure
(peroxisome proliferator-activated receptor-alpha, PPAR-a;
retinoid X receptor alpha, RXRa; uncoupling protein-2,
UCP2).10e12 Although we have demonstrated that our
formulated Mg-rich DSW drinking water upregulates low-
density-lipoprotein receptor and cholesterol-7a-hydroxylase
gene expression, which is partially related to a decrease in
serum cholesterol in hamsters fed a high-fat/cholesterol diet
hamsters,8 the information regarding effects of those Mg-rich
DSWs on other regulators of fatty-acid homeostasis in livers
was quite limited. Additionally, a high-fat dietary habit results
in hepatic lipid peroxidation when hepatic malondialdehyde
(MDA) contents are increased, thus increasing probabilities of
hepatic inflammation and steatosis.13,14 Trolox equivalent
antioxidant capacity (TEAC) and glutathione (GSH) are often
used to evaluate antioxidative levels in biological systems.14,15
Lowered lipid peroxidation could alleviate liver damage in
a high-fat-diet-induced hepatotoxicity. Therefore, the present
study investigated whether DSW drinking water in high-fatdiet hamsters could: (1) regulate hepatic fatty-acid homeo-
stasis; (2) improve hepatic antioxidative levels; and (3)
attenuate hepatic damage.
2. Methods2.1. Manufacture of DSW drinking watersThe collection and processing procedures of drinking water
from DSW were according to our previous method.8 Original
DSW samples were collected from a depth of approximately
618 m in Chisingtan Bay, Hua-Lien County, Taiwan at the same
time. Collected original DSW was treated with RO and ED to
reduce the mineral contents, especially sodium (Na). DSW
drinking waters (300, 900, and 1500 ppm) were formulated via
a combination of RO and ED. DSW drinking waters were also
pasteurized (80C, 60 seconds) and immediately stored ate20C
until fed to the hamsters. The mineral contents of DSW drinking
waters were analyzed using an inductively optical emission
spectrometer (JY ULTIMA 2000, Horiba, France) and are shown
in Table 1.2.2. Animals and dietsThe animal usage and protocol were reviewed and
approved by the National Taiwan University Animal Care
Committee. Thirty-two male Golden Syrian hamsters aged 5
weeks were purchased from the National Laboratory Animal
Center (National Science Council, Taipei, Taiwan). Two
hamsters were housed in each cage in an animal room at
22  2C with a 12 hour/12 hour light/dark cycle and fed
standard chow diets (Laboratory Rodent Diet 5001, 5% lipid/
0% cholesterol) with distilled water for 1 week. After the
acclimation period, all hamsters were fed a high-fat diet,
which was formulated as 92.8% (w/w) chow diets supple-
mented with 7% (w/w) butter and 0.2% (w/w) cholesterol.
At the beginning of experiment, two hamsters per cage were
randomly assigned to one of the following groups: (1) normal
distilled water (NDW); (2) 300 ppm DSW drinking water
(DSW300); (3) 900 ppmDSWdrinkingwater (DSW900); or (4)
1500 ppm DSW drinking water (DSW1500). All hamsters were
fed the high-fat diets and assigned drinking solutions (NDW,
DSW300, DSW900, or DSW1500) ad libitum for 6 weeks.
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before euthanasia by CO2, after which the heart, liver, and
kidney from each hamster were removed and weighed. The
liver was stored at e80C for further analyses. Blood samples
were also collected by intracardiac puncture. Sera were
separated from blood samples by centrifugation at 3000g for
10 minutes, and then stored at e80C for further analyses.
Feces were collected from each cage 24 hours before the end
of the experiment and stored at e20C for further analyses.2.4. Serum biochemical values, liver lipids, and fecal
lipids/bile acidSerum total cholesterol (TC) and triglyceride (TG), and
liver damage indices [aspartate aminotransferase (AST) and
alanine aminotransferase (ALT)] were determined using
commercial enzymatic kits with the SPOTCHEM EZ SP-4430
automated analyzer (ARKRAY, Inc., Kyoto, Japan). Liver TC/
TG and fecal TC/TG/bile acid concentrations were measured
using the technique of a previous study.14 Briefly, hepatic or
fecal lipid was extracted by chloroform and methanol (2:1, v/
v). The extract was dried under N2 and resuspended in iso-
propanol. Triglyceride, cholesterol, and bile acid concentra-
tions were measured using commercial kits (Randox
Laboratories Ltd., Crumlin, Antrim, UK) and multiplied with
daily fecal weight (g) to obtain daily fecal cholesterol,
triglyceride, and bile acid outputs.2.5. Hepatic MDA and GSH contents, and TEACA 0.5 g sample of liver was homogenized on ice in 4.5 mL
phosphate-buffered saline (PBS, pH 7.0, containing 0.25M
sucrose) and centrifuged at 12,000g for 30 minutes. The
supernatant was collected for further analyses. The protein
content in the supernatant was measured according to the
procedures of a Bio-Rad protein assay kit (Cat#: 500-0006;
Bio-Rad Laboratories, Inc., Hercules, CA, USA) and using
bovine serum albumin as a standard.
The hepatic MDA and GSH contents were measured
according to procedures described by Fang et al.16 The hepatic
MDA content was calculated by taking the extinction coeffi-
cient of MDA to be 1.56105 M1cm1 at 535 nm by using
a UV Visible Spectrophotometer (Model T60; PG Instruments
Ltd., Wibtoft, Leicestershire, UK). Due to the unique thiol
compound in GSH, 2,2-dithiobisnitrobenzoic acid (DTNB) is
commonly used for thiol assay. The hepatic GSH content was
calculated the GSH content by taking the extinction coefficient
of 2-nitro-5-thiobenzoic acid (NTB) to be 1.36  104 M1
cm1 at 412 nm by using a UV Visible Spectrophotometer
(PG Instruments Ltd.). Hepatic TEAC was analyzed according
to a method described by Chang et al.14 A free radical, 2,20-
azino-bis(3-ethylbenzothiazoline-6-sulfonic acidþ) (ABTSþ),
can be generated by mixing ABTS (100 mM) with H2O2
(50 mM) and peroxidase (4.4 U/mL). The TEAC value was
expressed as a scavenging capacity against ABTSþ. Briefly,0.25 mL of mixture of ABTS, H2O2, and peroxidase, and
1.5 mL dd H2O were mixed well and placed under a dark
room. After 30 minutes, 0.25 mL diluted liver homogenate
(1%, v/v) was then added. Absorbance was measured at
734 nm after the interaction of sample solution for 10 minutes.
The decrease in absorption at 734 nm after the addition of
reactant was used to calculate the TEAC value. A standard
curve was plotted for Trolox on scavenging ABTSþ capacity
and was calculated as the TEAC. A higher TEAC value of
a sample results in stronger antioxidant activity.2.6. Hepatic gene expressionsTotal RNAwas isolated from the stored frozen liver tissues by
using the protocol described by RNeasy Mini Kits (Qiagen,
Valencia, CA, USA). Reverse transcription was carried out with
2 mg total RNA, 8 mL reaction buffer, 2 mL dNTPs, 4.8 mLMgCl2,
4 mL Oligo-dT (10 pM), and 200 U RTase (Promega, Madison,
WI, USA) with diethyl pyrocarbonate H2O in a final volume of
40 mL at 42C for 1 hour. After heat inactivation, 1 mL cDNA
product was used for PCR amplification. The appropriate primers
of target genes were designed for hamster SREBP-1c (GenBank
no.: U09103), ACC (GenBank no.: AF356089), FAS (GenBank
no.: AF356086), ME (GenBank no.: NM008615), PPAR-
a (GenBank no.: NM001113418.1), RXRa (GenBank no.:
NM_002957), UCP2 (GenBank no.: NM_011671.4), and GAP
DH (GenBank no.: XR031141) as follows: SREBP-1c sense 50-G
GTGGGCACTGAGGCAAAGC-30, antisense 50-CGCACACA
GGGCTAGGCGGG-30; ACC sense 50-GGTGGTGGCATTGA
AGGAGC-30, antisense 50-CCACATAAGAGTTGGGAGAC-30;
FAS sense 50-AGCCCCTCAAGTGCACAGTG-30, antisense 50-
CACGTGTATGCCCTGGCGCC-30; ME sense 50-TCAGACAG
TGCTGTTCCAGG-30, antisense 50-GTTCATGGGCAAACA
CCTCT-30; PPAR-a sense 50-GGACAAGGCCTCAGGGTAC
C-30, antisense 50-CCACCATCTTGGCCACAAGC-30; RXRa:
sense 50-TGCTGCGGGCAGGCTGGAATGA-30, antisense 50-G
TCAG CACCCGATCAAAGAT-30; UCP2: sense 50-TCCC
TTGCCACTTCACTTCT-30, antisense 50-GCTGCTCATAGG
TGACAAACA-30; GAPDH sense 50-GACCCCTTCATTGACC
TCAAC-30, antisense 50-GGAGATGATGACCCTTTTGGC-30.
The sizes of reaction productswere: for SREBP-1c, 412 bp;ACC:
362 bp; FAS, 347 bp; ME: 191 bp; PPAR-a, 421 bp; RXRa,
154 bp; UCP2, 239 bp; GAPDH, 264 bp. GAPDHwas used as an
internal control in all reactions. The PCR amplifications were
performed under conditions using aDNA thermal cycler (ASTEC
PC-818, ASTEC Co., Ltd., Fukuka, Japan) under the following
conditions: SREBP-1c and FAS: 35 cycles of 94C for 1 minute,
55Cfor 1minute, and 72Cfor 2minutes followedby 10minutes
at 72C;ACC andME: 40 cycles of 94C for 1minute, 56C for 1
minute, and 72C for 2 minutes followed by 10 minutes at 72C;
PPAR-a: 25 cycles of 94C for 1 minute, 55C for 1 minute, and
72C for 2 minutes followed by 10 minutes at 72C; RXRa and
UCP2: 38 and 41 cycles, respectively, at 94C for 1 minute, 55C
for 1 minute, and 72C for 2 minutes followed by 10 minutes at
72C;GAPDH:25 cyclesof94Cfor1minute, 52Cfor 1minute,
and 72C for 2minutes followed by 10minutes at 72C. The final
products were subjected to electrophoresis on a 2% agarose gel
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expression levels of the mRNAs of the target genes were
normalized using the GAPDH internal standard.2.7. Histopathological analysisFor histopathological study, the liver tissues were placed in
formalin for no longer than 24 hours and were fixed in neutral-
buffered formalin solution, dehydrated in graded alcohol,
cleared in xylene, and embedded in paraffin. These blocks
were later sectioned using a microtome, dehydrated in graded
alcohol, embedded in paraffin section, and stained with
hematoxylin and eosin.2.8. Statistical analysisThe experiment was conducted using a completely random
design. Data were analyzed using analysis of variance. A
significant difference was identified at 0.05 probability level
and differences between treatments were tested using the
least significant difference test. All statistical analyses of data
were performed using SAS software (SAS Institute, Inc.,
Cary, NC, USA).
3. Results3.1. Weight gain, organ sizes, serum/liver lipids, liver
histological analysis, liver damage, and daily fecal lipid/
bile acid outputNo significant differences ( p > 0.05) in weight gain (g and
%), and heart and kidney sizes were observed among groups,
but liver sizes of high-fat diet hamsters were reduced
( p < 0.05) by drinking DSWs (Table 2). Decreased ( p < 0.05)
serum/liver lipids (TC and TG) of high-fat diet hamsters were
also observed after 6 weeks of drinking DSWs (Table 2).
Based on the histological examination of hamsters’ livers,
there was accumulation of lipid drops in liver cells in high-fat
diet hamsters, but drinking DSWs apparently decreased themTable 2
Weight gain, serum lipids, organ sizes, liver lipids, and liver damage indices of th
Group NDW D
Weight gain (g) 24.19  1.32a
Weight gain (%) 30.34  1.76a
Heart size (g/100 g body weight) 0.42  0.01a
Kidney size (g/100 g body weight) 0.95  0.02a
Liver size (g/100 g body weight) 4.42  0.05a
Serum
Cholesterol (mg/dL) 222.30  6.45a 1
Triglyceride (mg/dL) 211.36  3.00a
Liver
Cholesterol (mg/g tissue) 32.71  1.19a
Triglyceride (mg/g tissue) 28.73  0.95a
Liver damage index
AST (U/L) 68.13  2.70a
ALT (U/L) 124.88  3.24a 1
Values are means  SEM (n ¼ 8). Mean values with different letters within each(Fig. 1A vs. 1Be1D). Regarding the liver damage indices,
serum AST values of high-fat diet hamsters were also atten-
uated ( p < 0.05) by drinking DSW300, -900, and -1500
groups; however, lower ( p < 0.05) serum ALT values were
observed in both DSW900 and DSW1500 groups compared to
the NDW group (Table 2). Additionally, drinking DSWs
increased ( p < 0.05) daily fecal cholesterol, triglyceride, and
bile acid outputs of high-fat diet hamsters while DSW1500
group had the most ( p < 0.05) fecal bile acid output followed
by DSW900, DSW300, and NDW groups (Table 3).3.2. Lipid antioxidative status and fatty-acid
homeostasis in liversMDA levels were used to evaluate the oxidative level in
livers, and GSH and TEAC were used to assess the anti-
oxidative levels in livers. High-fat diet hamsters drinking
DSW drinking waters had lower ( p < 0.05) liver MDA
contents when compared to those only drinking NDW
(Fig. 2A). In hepatic GSH levels, although only high-fat diet
hamsters drinking DSW1500 had higher ( p < 0.05) GSH
levels than those drinking NDW, there was a tendency toward
higher GSH levels in high-fat diet hamsters drinking DSW300
and DSW900 compared to NDW (Fig. 2B). Regarding the
total antioxidative level in livers, the TEAC values in high-fat
diet hamsters were elevated ( p < 0.05) by drinking DSWs
(Fig. 2C). Expression of genes related to fatty-acid homeo-
stasis (SREBP-1c, ACC, FAS, ME, PPAR-a, RXRa, and
UCP2) of hamsters after 6 weeks of feeding, are illustrated in
Fig. 3. In fatty acid biosynthesis, DSWs did not ( p > 0.05)
alter SREBP-1c, ACC, FAS, and ME gene expression.
However, DSWs (especially DSW1500) upregulated
( p < 0.05) PPAR-a, RXRa, and UCP2 gene expression, which
triggers b-oxidation of fatty acids in livers.
4. Discussion
Generally, high-fat diets significantly increase body and liver
weights, leading to obesity, hyperlipidemia, and hepatice experimental hamsters.
SW300 DSW900 DSW1500
24.47  1.36a 22.33  1.70a 22.10  2.09a
29.78  1.91a 27.76  2.03a 27.19  2.59a
0.40  0.01a 0.40  0.00a 0.41  0.01a
0.95  0.01a 0.95  0.02a 0.97  0.02a
4.07  0.05b 3.97  0.04b 4.05  0.03b
81.48  4.24b 176.51  1.39b 148.29  3.94c
165.5  93.29b 161.13  7.30b 159.12  6.78b
20.97  0.83b 20.18  0.98bc 17.93  0.77c
18.90  0.44b 19.06  0.45b 18.82  0.56b
58.29  2.88b 55.50  3.34b 57.00  3.64b
19.43  2.64ab 113.75  3.79b 109.13  4.40b
test parameter differ significantly ( p < 0.05).
Fig. 1. Histological appearance of the liver section of the experimental hamsters (200). Histological appearance of hematoxylin and eosin-stained liver sections
from the experimental hamsters. (A) NDW, (B) DSW300, (C) DSW900, (D) DSW1500. Scale bar, 50 mm.
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Mg, and K.7 Our formulated DSW drinking waters are also rich
in Mg, Ca, and K (Table 1). Mg and Ca supplementations can
lower serum lipids and body weight/fat.18,19 Although no
difference in weight gain (g and%) among groups was observed
during the experimental period, there was a tendency toward
lower weight gain (g and %) in high-fat dietary hamsters
drinking DSW drinking waters, especially DSW900 and
DSW1500 (Table 2). Moreover, the hypolipidemic effect of
DSW was mainly attributed to its high Ca and Mg contents.7,20
However, because of highmineral contents in the original DSW,
especially Na, we treated it via RO and ED to reduce minerals,
and then formulated Mg-rich DSW300 (hardness: 325 ppm),
DSW900 (hardness: 859 ppm), and DSW1500 (hardness:
1570 ppm; Table 1). A high-salt/-Na dietary habit can cause
hypertension and renal hypertrophy or even renal fibrosis.21
However, those DSW drinking waters did not alter heart rate,
systolic blood pressure, diastolic blood pressure, or mean arte-
rial pressure of hamsters during the feeding period.8 No differ-
ences were observed in kidney and heart sizes during the 6
weeks of feeding, implying that our formulated DSW drinking
waters did not harm the kidney or heart (Table 2).
The reduced liver cholesterol content can be partially
accounted for by higher cholesterol secretion into bile, thusTable 3
Daily fecal cholesterol, triglyceride, and bile acid outputs of the experimental ham
Group NDW
Fecal cholesterol (mg/hamster/day) 0.82  0.13b
Fecal triglyceride (mg/hamster/day) 18.01  0.62b
Fecal bile acid (mg/hamster/day) 0.23  0.05c
Values are means  SEM (n ¼ 4). Mean values with different letters within eachleading to a depletion of the intrahepatic pool of cholesterol;
furthermore, a higher fecal lipid excretion was also related to
the lower serum lipid level, thus alleviating the hepatic lipid
accumulation.14 Therefore, it is speculated that the lipid-
lowering effect of DSWs (DSW300, -900, and -1500) on
liver lipids is highly associated with increased daily fecal
cholesterol, triglyceride, and bile acid excretions (Tables 2 and
3; Fig. 1). Regarding the hepatoprotection of DSW, Yoshioka
et al investigated the therapeutic effects of DSW (hardness 28,
300, and 1200) on hyperlipidemic rabbits.22 They reported no
decreases of serum AST and ALT values in those hyper-
lipidemic rabbits receiving DSWs for 4 weeks, but the degree
of lipid accumulation in livers was found to be less in DSW-
treated groups via histological examination. However, our
data showed that the liver damage indices (ASL and ALT
values) were lowered in high-fat diet hamsters drinking
DSWs, and less lipid accumulation in livers was observed
(Table 2; Fig. 1). This difference may be due to the different
animal models (rabbits vs. hamsters) and different treatments
of experiments (hyperlipidemic rabbits with normal diets for 4
weeks vs. hamsters with high-fat/cholesterol diets for 6
weeks).
Liver antioxidative status is highly related to liver
health.13,15,23 MDA is often used to evaluate the oxidativesters.
DSW300 DSW900 DSW1500
1.89  0.19a 1.95  0.35a 2.11  0.39a
22.38  1.31a 21.20  0.82a 20.84  0.51a
0.54  0.04b 0.56  0.06b 0.71  0.05a
test parameter differ significantly ( p < 0.05).
Fig. 2. Hepatic MDA, GSH, and TEAC of the experimental hamsters. Values are means  SEM (n ¼ 8). Bars with different letters differ significantly ( p < 0.05).
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caloric dietary habit easily increases liver lipid accumulation
and causes oxidative stress in the body, further enhancing liver
MDA contents and liver damage. Hence, the liver MDA
content could be an indicator to represent the liver perox-
idation status why liver GSH and TEAC were used to evaluate
liver antioxidative levels. Interestingly, drinking DSW
decreased liver MDA contents and maintained higher liverFig. 3. Relative mRNA expressions of sterol regulatory element-binding protein-1c
enzyme (ME), peroxisome proliferator-activated receptor-alpha (PPAR-a), retinoi
mental hamsters. Values are means  SEM (n ¼ 8). Bars with different letters wiGSH and TEAC levels, which could result from less hepatic
lipid accumulation (Figs. 1 and 2; Table 2). Moreover, higher
liver MDA contents are always coupled with liver damage,
which further increases serum AST and ALT values.1315,23
Similar results were also observed in the present study,
where drinking DSWs alleviated liver MDA contents, thus
resulting in lower serum AST and ALT values of high-fat
dietary hamsters (Fig. 2A; Table 2).(SREBP-1c), acetyl CoA carboxylase (ACC), fatty acid synthase (FAS), malic
d X receptor alpha (RXRa), and uncoupling protein-2 (UCP2) in the experi-
thin each target gene differ significantly ( p < 0.05).
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regulated by fatty-acid biosynthesis and energy expenditure.
SREBP-1c, ACC, FAS, and ME are key proteins and enzymes
in charge of fatty-acid biosynthesis.9 In addition, the upregu-
lation of expression of PPAR-a, RXRa, and UCP2 genes
results in higher b-oxidation of fatty acids in livers, thus
decreasing the development of hepatic steatosis.1012 RXRa is
a transcription factor and can form a heterodimer with PPAR-
a, thus promoting PPAR-a target gene expression. It was re-
ported that a PPAR-a agonist, Wy14,643, could restore the
DNA binding activity of PPAR-a/RXRa, inducing PPAR-
a target genes to stimulate the rate of b-oxidation of fatty
acids, and prevent fatty livers in ethanol-fed mice.10 Based on
current data, although no differences in SREBP-1c, ACC,
FAS, and ME gene expression were detected among groups,
expression of PPAR-a, RXRa, and UCP2 was upregulated by
drinking the DSW formulations. That means that the rate of b-
oxidation of fatty acids in livers was stimulated by DSW
drinking waters and corresponded to the lower lipid accumu-
lation in livers of high-fat diet hamsters (Figs. 1 and 3; Table
2). Additionally, it was also reported that PPAR-a can enhance
catalase activity and reduce oxidative stress,25 which is also in
line with higher PPAR-a expression and lower lipid perox-
idation status in livers of high-fat diet hamsters drinking
DSWs (Figs. 2 and 3).
Our previous study illustrated that DSW drinking water can
decrease serum lipids and keep higher serum antioxidative
status in high-fat diet hamsters.8 In the present study, we again
demonstrated that formulated DSW drinking water is charac-
terized as a hepatoprotective effect against a high-fat diet as
well. On the basis of current data, the protective effects of
DSWs against a high-fat diet are explained by: (1) lower lipid
accumulation in livers due to increased daily fecal lipid/bile
acid outputs; (2) upregulation of genes related to b-oxidation
of fatty acids, i.e. PPAR-a, RXRa, and UCP2; and (3) lower
lipid peroxidation status in livers. Therefore, DSW warrants
application as a hepatoprotective ingredient against nonalco-
holic hepatosteatosis induced by a high-fat diet in the future.
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